Pathophysiology and Management of Acute Coronary Syndromes

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast from the BMJ Group, Mark de Belder, MD, a consultant cardiologist, speaks to James McLenachan, MRCP, a fellow consultant cardiologist, and Keith Channon, MD, professor of cardiovascular medicine at the University of Oxford, about the pathophysiology and management of acute coronary syndromes. To listen to the podcast online, click here. To download it, click here.
Related Articles
Leading groups fighting chronic disease argue that Congress intended for eligible consumers to receive tax credits that help make health coverage bought in either federal or state-run marketplaces more affordable.
The FDA has approved a new treatment for adults who experience bleeding episodes from a rare and potentially life-threatening form of hemophilia.
Adults aged 50 years or older who feel comfortable about aging are more likely to seek preventive health care services.
Even though smoking can exacerbate respiratory conditions and limit the efficacy of their treatment, patients often purchase cigarettes while filling prescriptions for asthma or antihypertensive drugs at pharmacies.
Latest Issues
$auto_registration$